… Therefore, the purpose of our study was to investigate whether radiomics features from (
18 F)-FDG PET/CT in patients with lung adenocarcinoma combined with clinical data can …

… Small-cell lung cancer (SCLC) is one of the most aggressive cancers with frequent recurrence,
even after an initial favourable response to cytotoxic treatments. In the USA, despite the …

… The risk of lung cancer-specific death (defined as cumulative incidence of lung cancer-specific …
using a cumulative incidence function, which accounted for death from other than lung …

… , should have a role in medical decision-making, particularly in stage IV oligometastatic …
better than what that stage typically implies [2]. Non-small cell lung cancer (NSCLC) occasionally …

… Patients with FDG-PET/computed tomography stage I-III NSCLC were prescribed concurrent
chemotherapy and radiation therapy (60 Gy in 30 fractions). Scans were acquired at …

… Figure 2 shows the Graphic representation of performance of conventional imaging versus
positron emission tomography-computerised tomography in detecting nodal metastasis in …

… of circulating tumor cells (CTCs) might be predictors of tumor … in patients with non-small cell
lung cancer (NSCLC). Secondly, we … tumor on a positron emission tomographic (PET) scan. …

… -stage IA non-small cell lung cancer (NSCLC), excluding pure ground glass nodular (pGGN)
lung cancer, which … These results underscore the importance of careful consideration for the …

… The reason their findings differed from our own may be because their study included patients
with early-stage (I to II) lung cancer. Early-stage lung cancer patients can be expected to …

Background Angiogenesis assessment is important for personalized therapeutic intervention
in patients with non-small-cell lung cancer (NSCLC). This study investigated whether …